0

Date:

advanced Search
  • Photographer
  • Country
  • State
  • From Date
  • To Date

Search for a Photo, Category & Sub Category, Photo ID, Special Collection, Keywords, Personalities, Events, Year Wise.

Return to Search Result

SHAH_RUKH_KHAN

Image ID: 9411614

Caption : Actor Shahrukh Khan addresses at the launch of World's first humanized anti-EGFR monoclonal antibody Biocon Cancer Drug, 'BIOMAB-EGFR' in Bangalore on September 17, 2006. Photo: G.P. Sampath Kumar

Image Type Dimensions (Pixels) (W Χ H) (Px) (W Χ H) Resolutions Price
336x457 72DPI $ 28 /-
504x685 72DPI $ 34 /-
600x816 300DPI $ 68 /-
1720x2340 300DPI $ 137 /-

*Non-Exclusive usage over a period of time
Exclusive Duration Price
$ 557 /-
$ 749 /-
$ 877 /-
$ 1,015 /-
$ 1,208 /-

Photographer :G P Sampath kumar
Category:
Health
Sub-Category: MEDICINE
Credit: THE HINDU

Creation Date: 2006-09-17
Image Size: 1720 x 2340 pixels
File Size: 2 MB

City : BANGALORE
State : KARNATAKA
Country :INDIA

View : 53 Times
Download : 0 Times
0000-00-00 00:00:00

Keywords

ACTOR , SHAHRUKH KHAN , ADDRESSES , DRUG , CANCER , BIOCON CANCER DRUG , LAUNCH , BIOMAB EGFR , BANGALORE

Enter muliple keywords by comma seperator
Eg: key1, key2, key3
Related Keywords
    ****slplit******array(17) { [0]=> string(4) "DRUG" [1]=> string(6) "CANCER" [2]=> string(18) "BIOCON CANCER DRUG" [3]=> string(6) "LAUNCH" [4]=> string(5) "ACTOR" [5]=> string(13) "SHAHRUKH KHAN" [6]=> string(19) "KIRAN MAZUMDAR SHAW" [7]=> string(11) "BIOMAB EGFR" [8]=> string(9) "BANGALORE" [9]=> string(5) "ACTOR" [10]=> string(13) "SHAHRUKH KHAN" [11]=> string(4) "DRUG" [12]=> string(6) "CANCER" [13]=> string(18) "BIOCON CANCER DRUG" [14]=> string(6) "LAUNCH" [15]=> string(11) "BIOMAB EGFR" [16]=> string(9) "BANGALORE" }
  • KIRAN MAZUMDAR SHAW
  • BIOMAB EGFR
Currency-****USDIP-****3.239.119.61CountryCode-****ipin-****
related images
last viewed
  • Related Images

Last viewed

Kasturi Buildings, 859 & 860, Anna Salai, Chennai 600002, India. Tel: +91 44 2857 6300 / 2857 6608

© 2004 The Hindu Images, All Rights Reserved.
Top